Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EPOPROSTENOL Cause Staphylococcal infection? 139 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 139 reports of Staphylococcal infection have been filed in association with EPOPROSTENOL (EPOPROSTENOL). This represents 1.0% of all adverse event reports for EPOPROSTENOL.

139
Reports of Staphylococcal infection with EPOPROSTENOL
1.0%
of all EPOPROSTENOL reports
17
Deaths
125
Hospitalizations

How Dangerous Is Staphylococcal infection From EPOPROSTENOL?

Of the 139 reports, 17 (12.2%) resulted in death, 125 (89.9%) required hospitalization, and 2 (1.4%) were considered life-threatening.

Is Staphylococcal infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EPOPROSTENOL. However, 139 reports have been filed with the FAERS database.

What Other Side Effects Does EPOPROSTENOL Cause?

Dyspnoea (2,744) Headache (2,425) Diarrhoea (2,310) Nausea (2,016) Pain in jaw (1,928) Death (1,362) Flushing (1,256) Fatigue (1,133) Hospitalisation (1,078) Vomiting (1,068)

What Other Drugs Cause Staphylococcal infection?

ADALIMUMAB (1,727) METHOTREXATE (932) PREDNISONE (914) ETANERCEPT (850) TACROLIMUS (777) MYCOPHENOLATE MOFETIL (677) CYCLOPHOSPHAMIDE (625) RITUXIMAB (582) INFLIXIMAB (561) SECUKINUMAB (525)

Which EPOPROSTENOL Alternatives Have Lower Staphylococcal infection Risk?

EPOPROSTENOL vs EPTIFIBATIDE EPOPROSTENOL vs EPTINEZUMAB-JJMR EPOPROSTENOL vs EPTINEZUMAB\EPTINEZUMAB-JJMR EPOPROSTENOL vs EQUINE BOTULINUM NEUROTOXIN A/B/C/D/E/F/G IMMUNE FAB2 EPOPROSTENOL vs EQUINE THYMOCYTE IMMUNE GLOBULIN

Related Pages

EPOPROSTENOL Full Profile All Staphylococcal infection Reports All Drugs Causing Staphylococcal infection EPOPROSTENOL Demographics